Table 2 Haplotype distribution of 53BP1 polymorphismsa in breast cancer patients and control individuals
From: TP53-binding protein variants and breast cancer risk: a case-control study
Cases | Controls | ORb | 95 % CI | P | |||
|---|---|---|---|---|---|---|---|
Haplotype 1059C>G-1234G>A-1347_1352-/+-3406A>C | No. (%) | Mean posterior probability | No. (%) | Mean posterior probability | |||
CG+A | 444 (68.1) | 1 | 1242 (67.5) | 1 | 1 | - | - |
CG+C | 2 (0.3) | 1 | 1 (0.1) | 1 | n.a. | n.a. | n.a. |
CG–A | 6 (0.9) | 0.90 | 25 (1.4) | 0.99 | 0.63 | 0.23–1.75 | 0.38 |
GG+A | 1 (0.2) | 1 | 1 (0.1) | 1 | n.a. | n.a. | n.a. |
GG+C | 125 (19.2) | 1 | 376 (20.4) | 1 | 1.02 | 0.79–1.33 | 0.86 |
GA+C | 74 (11.3) | 1 | 195 (10.6) | 1 | 1.15 | 0.83–1.61 | 0.41 |